The Pharmacogenomics Journal - Table of Contents alert Volume 12 Issue 5

TABLE OF CONTENTS Volume 12, Issue 5 (October 2012) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe   Translational Psychiatry now indexed by Thomson Reuters Web of Science We are pleased to inform you that Translational Psychiatry has qualified for coverage in Thomson Reuters products and services and is now indexed and abstracted in: - Web of Science - MEDLINE - PubMed   Review Top Heterochromatin as an incubator for pathology and treatment non-response: implication for neuropsychiatric illness R P Sharma, D P Gavin and K A Chase Pharmacogenomics J 2012 12: 361-367; advance online publication, January 17, 2012; 10.1038/tpj.2011.64 Abstract | Full Text Original Articles Top Gene expression in blood is associated with risperidone response in children with autism spectrum disorders L Lit, F R Sharp, K Bertoglio, B Stamova, B P Ander, A D Sossong and R L Hendren Pharmacogenomics J 2012 12: 368-371; advance online publication, June 7, 2011; 10.1038/tpj.2011.23 Abstract | Full Text Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region Y Hu, E A Ehli, J J Hudziak and G E Davies Pharmacogenomics J 2012 12: 372-378; advance online publication, June 7, 2011; 10.1038/tpj.2011.24 Abstract | Full Text Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia J Salazar, A Altés, E del Río, J Estella, S Rives, M Tasso, A Navajas, J Molina, M Villa, J L Vivanco, M Torrent, M Baiget and I Badell Pharmacogenomics J 2012 12: 379-385; advance online publication, July 12, 2011; 10.1038/tpj.2011.25 Abstract | Full Text Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia M Ansari, G Sauty, M Labuda, V Gagné, J Rousseau, A Moghrabi, C Laverdière, D Sinnett and M Krajinovic Pharmacogenomics J 2012 12: 386-394; advance online publication, May 24, 2011; 10.1038/tpj.2011.17 Abstract | Full Text Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704 J J Farrell, K Bae, J Wong, C Guha, A P Dicker and H Elsaleh Pharmacogenomics J 2012 12: 395-403; advance online publication, May 31, 2011; 10.1038/tpj.2011.22 Abstract | Full Text TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials P P Grimminger, M Shi, C Barrett, D Lebwohl, K D Danenberg, J Brabender, C L P Vigen, P V Danenberg, T Winder and H-J Lenz Pharmacogenomics J 2012 12: 404-411; advance online publication, July 26, 2011; 10.1038/tpj.2011.29 Abstract | Full Text Genetic clustering of European cancer patients indicates that opioid-mediated pain relief is independent of ancestry A Galvan, T Fladvad, F Skorpen, X Gao, P Klepstad, S Kaasa and T A Dragani Pharmacogenomics J 2012 12: 412-416; advance online publication, July 12, 2011; 10.1038/tpj.2011.27 Abstract | Full Text Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design E J Do, P Lenzini, C S Eby, A R Bass, G A McMillin, S M Stevens, S C Woller, R C Pendleton, J L Anderson, P Proctor, R M Nunley, V Davila-Roman and B F Gage Pharmacogenomics J 2012 12: 417-424; advance online publication, May 24, 2011; 10.1038/tpj.2011.18 Abstract | Full Text Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations K Song, M R Nelson, J Aponte, E S Manas, S-A Bacanu, X Yuan, X Kong, L Cardon, V E Mooser, J C Whittaker and D M Waterworth Pharmacogenomics J 2012 12: 425-431; advance online publication, May 24, 2011; 10.1038/tpj.2011.20 Abstract | Full Text Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms P Maltese, L Palma, C Sfara, P de Rocco, A Latiano, O Palmieri, G Corritore, V Annese and M Magnani Pharmacogenomics J 2012 12: 432-438; advance online publication, July 26, 2011; 10.1038/tpj.2011.26 Abstract | Full Text Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and −202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency E F Costalonga, S R R Antonini, G Guerra-Junior, R R D Coletta, M M Franca, A F Braz, B B Mendonca, I J P Arnhold and A A L Jorge Pharmacogenomics J 2012 12: 439-445; advance online publication, April 5, 2011; 10.1038/tpj.2011.13 Abstract | Full Text Background gene expression networks significantly enhance drug response prediction by transcriptional profiling A Torkamani and N J Schork Pharmacogenomics J 2012 12: 446-452; advance online publication, August 9, 2011; 10.1038/tpj.2011.35 Abstract | Full Text   Advertisement The Pharmacogenomics Journal's new impact factor is 4.536!* For worldwide visibility and rapid publication, publish your papers in The Pharmacogenomics Journal. • Receive a first decision on your paper within 40 working days • An average of 30,000 page views across The Pharmacogenomics Journal web site per month • Over 143,000 recipients receive via e-mail a table of contents alert for The Pharmacogenomics Journal issue in which your article is published Submit your article today! *2011 Journal Citation Reports® (Thomson Reuters, 2012)   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.